1. Home
  2. CFLT vs RGEN Comparison

CFLT vs RGEN Comparison

Compare CFLT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.08

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
RGEN
Founded
2014
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CFLT
RGEN
Price
$30.08
$157.57
Analyst Decision
Buy
Buy
Analyst Count
33
10
Target Price
$30.21
$170.90
AVG Volume (30 Days)
17.1M
696.6K
Earning Date
10-27-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$1,113,149,000.00
$707,890,000.00
Revenue This Year
$22.76
$17.84
Revenue Next Year
$16.57
$12.57
P/E Ratio
N/A
$6,185.26
Revenue Growth
21.57
11.74
52 Week Low
$15.64
$102.97
52 Week High
$37.90
$182.52

Technical Indicators

Market Signals
Indicator
CFLT
RGEN
Relative Strength Index (RSI) 78.69 47.50
Support Level $22.91 $160.11
Resistance Level $30.23 $165.02
Average True Range (ATR) 0.54 4.97
MACD 0.88 -1.27
Stochastic Oscillator 98.41 7.12

Price Performance

Historical Comparison
CFLT
RGEN

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: